Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems

Cairo University (CU)

Status: Enrolling

Conditions: Subclinical hypothyroïdism; Cognitive Impairment

Treatments: Behavioral: Baduanjin exercising

Study type: Interventional

Funder types: Other

Identifiers

NCT05803967

P.T.REC/012/004294

Details and patient eligibility

About

Females with sub-clinical hypothyroidism may exhibit frequent cognitive problems especially if they are elderly

Full description

Females (forty in number) with sub-clinical hypothyroidism exhibit cognitive problems, they are elderly, will be divided to exercised group (baduanjin training will be applied 5 times per the week, under supervision for 12 weeks, number of patients will be 20) and other non exercised group (number of patients will be 20) . all women of groups will received their prescribed daily one-dose medication tablet (levothyroxine).

Enrollment: 40 estimated patients

Sex: Female

Ages: 65 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• female with sub-clinical hypothyroidism
• females with mild cognitive impairment
• females with obesity (obesity class one)

Exclusion criteria

• neurological problems
• orthopedic problems

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

group number 1

Experimental group

Description:

Females with sub-clinical hypothyroidism exhibit cognitive problems (mild cognitive impairement), they will be elderly, will receive baduanjin training that will be applied 5 times per the week, under supervision for 12 weeks, number of patients will be 20), also women of this group will receive their prescribed daily one-dose medication tablet (levothyroxine).

Treatment:

Behavioral: Baduanjin exercising

group number 2

No Intervention group

Description:

Females with sub-clinical hypothyroidism exhibit cognitive problems (mild cognitive impairement), they will be elderly, will receive will receive their prescribed daily one-dose medication tablet (levothyroxine).